OPA1 and lung carcinoma: In both in-vitro and in-vivo cases, western blot analysis indicated that FPS/siOPA1 had a higher silencing effect on OPA1 gene expression compared with other nanoparticles, and this makes FPS a potential therapeutic agent for treating lung cancer.